In mid-2022, Novitas MAC proposed a new LCD for oncology tests. In June 2023, it issued the final version, which was much longer with many topics not covered in the proposal. After stakeholder protests that this was "bait and switch," Novitas withdrew the final LCD.
And, days later, Novitas issued the "final LCD" of the 2022 proposal, as a new, "proposal" for 2023. Entry point here - from July 27, 2023.
This triggered a new round of public comments. I used AI to summarize the 21 presentations at a public hearing. Here.
Now, the clock has run out on the one-year time period to finalize the July 2023 draft LCD (which, recall, was the June 2023 final LCD of the 2022 proposal).
What's New? Still Thinking!
Novitas posts that CMS has granted it an extension (of unstated duration) to continue considering the public comments. Find it here:
https://www.novitas-solutions.com/webcenter/portal/MedicareJL/pagebyid?contentId=00006150
July 26, 2024
Novitas is considering all the feedback received from interested parties regarding the Genetic Testing for Oncology LCD. An extension has been granted by CMS in order for all comments to be considered thoroughly. Future updates will be published to this website and the Medicare Coverage Database. Please watch our website and consider subscribing to our mailing list for the most timely updates.
##
AI Corner
I asked Chat GPT to read this blog, and then, provide an illustration of its own choosing.
 |
| Chat GPT 4 |
